glp 1 drugs and autoimmune disease Frontiers GLP-1 Receptor Agonists and Autoimmune
Description
E., Smith, A
6 Department of Pharmaceutical Chemistry, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, 34212, Saudi Arabia
One potential future hurdle for the growth of the market for glucagon-like peptide 1 (GLP-1) agonists is the availability of suitable insurance
doi: 10.1177/2515690X20916123 209 ChackrewarthySThabrewMIWeerasuriyaMKBJayasekeraS
Individuals in both groups were more likely to be female and white
